Find verified Daridorexant hydrochloride API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Daridorexant hydrochloride for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Daridorexant hydrochloride API.
Alternate Names: Nemorexant Hydrochloride, Naimoreson HCl, ACT-541468 hydrochloride
CAS No: 1792993-84-0
PubChem CID: 91809208
Mol Formula: C23H24Cl2N6O2
Mol Weight: 487.4 g/mol
IUPAC Name: [(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone;hydrochloride
API Description: Daridorexant Hydrochloride is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 2022 and is indicated for insomnia.
